These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9813623)

  • 21. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine.
    Grases F; Rodriguez A; Costa-Bauza A
    J Urol; 2015 Sep; 194(3):812-9. PubMed ID: 25818031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological effects of glycosaminoglycans on calcium oxalate monohydrate crystals.
    Shirane Y; Kurokawa Y; Sumiyoshi Y; Kagawa S
    Scanning Microsc; 1995; 9(4):1081-8; discussion 1088. PubMed ID: 8819889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface studies of calcium oxalate dihydrate single crystals during dissolution in the presence of urine.
    Akbarieh M; Dubuc B; Tawashi R
    Scanning Microsc; 1987 Sep; 1(3):1397-403. PubMed ID: 3659870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controlling influence of phosphocitrate in vitro and in vivo on calcium oxalate crystal formation and growth.
    Sallis JD; Parry NF; Meehan JD; Kamperman H; Anderson ME
    Scanning Microsc; 1995 Mar; 9(1):127-35; discussion 135-6. PubMed ID: 8553011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal surface adhesion explains the pathological activity of calcium oxalate hydrates in kidney stone formation.
    Sheng X; Ward MD; Wesson JA
    J Am Soc Nephrol; 2005 Jul; 16(7):1904-8. PubMed ID: 15930089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urolithiasis inhibitors and calculus nucleation.
    Grases F; Gil JJ; Conte A
    Urol Res; 1989; 17(3):163-6. PubMed ID: 2546313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
    Sallis JD; Lumley MF
    Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface studies of calcium oxalate dihydrate single crystals during dissolution in the presence of stone-formers' urine.
    Akbarieh M; Tawashi R
    Scanning Microsc; 1989 Mar; 3(1):139-45; discussion 145-6. PubMed ID: 2740860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of glycoproteins in calcium oxalate crystal development.
    Grases F; Isern B; Perelló J; Costa-Bauzá A
    BJU Int; 2004 Jul; 94(1):177-81. PubMed ID: 15217456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial simulation of renal stone formation. Influence of some urinary components.
    Grases F; Costa-Bauzá A; March JG; Söhnel O
    Nephron; 1993; 65(1):77-81. PubMed ID: 8413796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic action of citrate in urolithiasis explained by chemical speciation: increase in pH is the determinant factor.
    Rodgers A; Allie-Hamdulay S; Jackson G
    Nephrol Dial Transplant; 2006 Feb; 21(2):361-9. PubMed ID: 16249202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of citrate and pyrophosphate on the stability of calcium oxalate dihydrate.
    Yuzawa M; Tozuka K; Tokue A
    Urol Res; 1998; 26(2):83-8. PubMed ID: 9631939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Calcium-dependent calcium oxalate lithiasis (type IIa). The importance of urinary citrate and the calcium/citrate ratio].
    Boess G; Parent X
    Presse Med; 1999 Apr; 28(15):784-6. PubMed ID: 10325933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of trace metals on the inhibition of calcium oxalate crystallization.
    Muñoz JA; Valiente M
    Urol Res; 2005 Aug; 33(4):267-72. PubMed ID: 15937709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adsorption of naturally occurring polymers onto calcium oxalate crystal surfaces.
    Leal JJ; Finlayson B
    Invest Urol; 1977 Jan; 14(4):278-83. PubMed ID: 64463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro.
    Kok DJ; Papapoulos SE; Blomen LJ; Bijvoet OL
    Kidney Int; 1988 Sep; 34(3):346-50. PubMed ID: 2459439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.